Diet, Other Risk Factors, Genetics and the Risk of Colorectal Neoplasia in a Screening Trial of Asymptomatic Women: A Sub-Study of the CONCeRN Trial
The CONCeRN Trial is a multi-center study of asymptomatic women between the ages of 40 and
75 referred to regional military medical centers for routine colorectal screening. The
primary purpose of the main study is to determine the extent to which advanced neoplastic
lesions will be missed if clinicians only perform sigmoidoscopies rather than full
colonoscopies as a screening procedure and to resolve current debate about the significance
of sigmoidoscopic detection of single, small, tubular adenomas (i.e., do they imply greater
risk for large adenomatous polyps or colorectal cancer at other sites beyond the reach of
the sigmoidoscope, or is there no increased risk?). Women enrolled in the trial receive
colonoscopy during which all identified polyps are removed and also during which two pinch
biopsies of apparently-normal tissue are taken. In addition, before the colonoscopy is
performed, patients will have blood drawn and answer a brief questionnaire on risk factors
for colorectal cancer. The NCI-led sub-study added a more extensive questionnaire to assess
dietary and other lifestyle factors potentially related to colorectal cancer, and obtained
additional blood for assessment of nutritional status and for analysis of genetic
polymorphisms related to colorectal cancer. With the additional information available from
these questionnaires and blood samples, it will be possible to explore the extent to which
various dietary and genetic risk factors are related to colorectal polyps in asymptomatic
women of average risk for disease. Recruitment is now complete at all sites. A total of
937 women were recruited. Of these, about one-quarter of the women with one or more
adenomas had an advanced adenoma, defined as being greater than or equal to 1 cm in
diameter, or having high grade dysplasia or villous elements). These neoplasia prevalence
figures are in line with initial projections. Active contact with participants is
concluded. We have now entered into a data analysis phase.
Observational
N/A
Amanda J Cross, Ph.D.
Principal Investigator
National Cancer Institute (NCI)
United States: Federal Government
999900010
NCT00339950
February 2000
Name | Location |
---|---|
National Naval Medical Center | Bethesda, Maryland 20889 |
Naval Medical Center, Portsmouth | Portsmouth, Virginia 23708-2197 |
Naval Medical Center, San Diego | San Diego, California 92134-5000 |